DE69103053D1 - Pharmazeutische Zubereitung für die Reifung von Prothymozythen. - Google Patents

Pharmazeutische Zubereitung für die Reifung von Prothymozythen.

Info

Publication number
DE69103053D1
DE69103053D1 DE69103053T DE69103053T DE69103053D1 DE 69103053 D1 DE69103053 D1 DE 69103053D1 DE 69103053 T DE69103053 T DE 69103053T DE 69103053 T DE69103053 T DE 69103053T DE 69103053 D1 DE69103053 D1 DE 69103053D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparation
prothymocytes
maturation
ige
prothymocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69103053T
Other languages
English (en)
Other versions
DE69103053T2 (de
Inventor
Patrice Prof Dr Debre
Mohammad Djavad Dr Mossalayi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE69103053D1 publication Critical patent/DE69103053D1/de
Application granted granted Critical
Publication of DE69103053T2 publication Critical patent/DE69103053T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69103053T 1990-01-24 1991-01-15 Pharmazeutische Zubereitung für die Reifung von Prothymozythen. Expired - Fee Related DE69103053T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909001625A GB9001625D0 (en) 1990-01-24 1990-01-24 A pharmaceutical preparation for maturation of prothymocytes

Publications (2)

Publication Number Publication Date
DE69103053D1 true DE69103053D1 (de) 1994-09-01
DE69103053T2 DE69103053T2 (de) 1994-12-01

Family

ID=10669826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69103053T Expired - Fee Related DE69103053T2 (de) 1990-01-24 1991-01-15 Pharmazeutische Zubereitung für die Reifung von Prothymozythen.

Country Status (11)

Country Link
US (1) US5236706A (de)
EP (1) EP0447353B1 (de)
JP (1) JPH05117163A (de)
AT (1) ATE109005T1 (de)
AU (1) AU643245B2 (de)
CA (1) CA2034737A1 (de)
DE (1) DE69103053T2 (de)
ES (1) ES2057833T3 (de)
GB (1) GB9001625D0 (de)
IE (1) IE910229A1 (de)
PT (1) PT96540A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601042D0 (en) * 1996-01-17 1996-03-20 Smithkline Beecham Plc Medical use
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
JPH11506902A (ja) * 1994-12-01 1999-06-22 ベス イズレイル ディーコネス メディカル センター インコーポレイテッド イン・ビトロｔリンパ球生成系
US6410714B1 (en) * 1999-03-24 2002-06-25 Heska Corporation Canine low affinity IgE receptor (CD23) nucleic acid molecules and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808611A (en) * 1986-07-30 1989-02-28 Immunex Corporation Use of interleukin-1 to induce development of multipotent hemopoietic cell populations
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies
US5135851A (en) * 1990-05-08 1992-08-04 Kajander E Olavi Culture and detection method for sterile-filterable autonomously replicating biological particles

Also Published As

Publication number Publication date
EP0447353A1 (de) 1991-09-18
IE910229A1 (en) 1991-07-31
GB9001625D0 (en) 1990-03-21
EP0447353B1 (de) 1994-07-27
ES2057833T3 (es) 1994-10-16
ATE109005T1 (de) 1994-08-15
AU6934791A (en) 1991-07-25
DE69103053T2 (de) 1994-12-01
US5236706A (en) 1993-08-17
AU643245B2 (en) 1993-11-11
JPH05117163A (ja) 1993-05-14
PT96540A (pt) 1991-10-31
CA2034737A1 (en) 1991-07-25

Similar Documents

Publication Publication Date Title
ATE84215T1 (de) Arzneizubereitung zur oralen anwendung.
DE69019716D1 (de) Medizinisches Gerät zur Laserbehandlung.
DE3783068D1 (de) Medizinische vorrichtung.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
DE69202739D1 (de) Gemischtes Alkylmethylsiloxane zur Hautpflege.
DE3876417D1 (de) Einmalfilter.
DE3677565D1 (de) Medizinische vorrichtung.
DE3864379D1 (de) Orthodontische behandlungsvorrichtung.
TR23901A (tr) Insektisid özellikte n-sübstitüe n,n'-diacilhidrazinler
DE58906881D1 (de) Gerät zur Zahnbehandlung.
DE3862490D1 (de) Mittel zur insekten- und milbenabwehr.
DE3871503D1 (de) Halbleiterlaservorrichtung und herstellung derselben.
DE3763507D1 (de) Patientenlagerungstisch.
ATE109005T1 (de) Pharmazeutische zubereitung für die reifung von prothymozythen.
DE58904845D1 (de) Zahnaerztliches saughandstueck.
DE3763140D1 (de) Patientenlagerungstisch.
DE3783401D1 (de) Medizinische roehre und herstellungsverfahren.
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
DK191089A (da) Biologisk aktive forbindelser
ES2094757T3 (es) Un factor megacariocitopoyetico.
DE68922150D1 (de) Vorrichtung zur elektrochemischen Behandlung.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE68919369D1 (de) Orthodontische behandlung.
DE3785305D1 (de) Medizinisches geraet.
DE69003722D1 (de) Zahnärztliches Handstück.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee